Skip to content
10-Q

Quarterly Report

BIOXYTRAN, INC. BIXT

0001493152-25-011797

← back to feed
Filed
Aug 11, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 8, 2025 88.99M sh
Shares Diluted Q2 2025 · Jun 30, 2025 88.84M sh
Shares Diluted Q2 2025 · Jun 30, 2025 88.94M sh
Shares Diluted Q2 2025 · Jun 30, 2024 176.61M sh
Shares Diluted Q2 2025 · Jun 30, 2024 171.26M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$248.01K
Operating Cash Flow restated Q2 2025 · Jun 30, 2024 −$179.83K
Short Term Debt Q2 2025 · Jun 30, 2025 $48.07K
Current Liabilities Q2 2025 · Jun 30, 2025 $2.78M
Current Liabilities Q2 2025 · Dec 31, 2024 $1.93M
Total Liabilities Q2 2025 · Jun 30, 2025 $2.78M
Total Liabilities Q2 2025 · Dec 31, 2024 $1.93M
Current Assets Q2 2025 · Jun 30, 2025 $3.14K
Current Assets Q2 2025 · Dec 31, 2024 $5.15K
Total Assets Q2 2025 · Jun 30, 2025 $147.5K
Total Assets Q2 2025 · Dec 31, 2024 $138.69K
Eps Diluted Q2 2025 · Jun 30, 2025 $0.00
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.01
Eps Diluted Q2 2025 · Jun 30, 2024 $0.00
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.01
Eps Basic Q2 2025 · Jun 30, 2025 $0.00
Eps Basic Q2 2025 · Jun 30, 2025 −$0.01
Eps Basic Q2 2025 · Jun 30, 2024 $0.00
Eps Basic Q2 2025 · Jun 30, 2024 −$0.01
Rd Expense Q2 2025 · Jun 30, 2025 $102.5K
Rd Expense Q2 2025 · Jun 30, 2025 $452K
Rd Expense Q2 2025 · Jun 30, 2024 $27K
Net Income Q2 2025 · Jun 30, 2025 $35.44K
Net Income Q2 2025 · Jun 30, 2025 −$1.32M
Net Income Q2 2025 · Mar 31, 2025 −$1.35M
Net Income restated Q2 2025 · Jun 30, 2024 −$661.65K
Net Income restated Q2 2025 · Jun 30, 2024 −$1.22M
Net Income restated Q2 2025 · Mar 31, 2024 −$560.52K
Operating Income Q2 2025 · Jun 30, 2025 −$224.08K
Operating Income Q2 2025 · Jun 30, 2025 −$739.22K
Operating Income restated Q2 2025 · Jun 30, 2024 −$609.32K
Operating Income restated Q2 2025 · Jun 30, 2024 −$1.39M